Home » Shelby Klug Begins Clinical Trial In Battle With CF

Shelby Klug Begins Clinical Trial In Battle With CF

Shelby Klug begins clinical trial

Shelby Klug, teen daughter of Popchips’ sales exec Todd Klug and Unified Grocers’ Sue Klug, has been accepted into a clinical trial that aims to cure the form of cystic fibrosis from which she suffers. Shelby took her first dose of medication as part of the trial earlier today in her home state of California.

The Phase 3 clinical trial includes the Vertex drugs 770 and 809, Shelby said earlier this year; 770, or Kalydeco, was approved by the FDA last year and provided a cure to 4 percent of the CF population, she added.

“The…clinical trial combines Kalydeco with another drug—Vertex 809—and it is aimed at curing my specific genetic mutation,” Shelby said then.

Go here to read more about Shelby’s upbeat attitude and her courageous battle with CF.


How Can Technology Help Independent Grocers In A Global Pandemic?

With a tremendous uptick in technology solutions in the industry, LOC Software discusses the technology trends and product innovations heading for the future in independent grocery.

Learn More

Learn how grocers of all sizes can engage Gen Z – the 67 million young people born between 1997 and 2012. Gen Z’s are the most racially and ethnically diverse of any generation.

They are the future of your business – your customers, your staff, and the influencers who will impact the buying preferences of your customers and the values of your staff.

Watch Now

Featured Photos

Featured Photo Illuminator Torch Awards, April 5
Anaheim Hilton
Anaheim, California
Share via
Copy link
Powered by Social Snap